nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine barbiturate—Phenobarbital—CYP1B1—melanoma	0.00355	0.379	CrCbGaD
Quinidine barbiturate—Quinine—ABCB1—melanoma	0.00256	0.273	CrCbGaD
Quinidine barbiturate—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.00239	0.00339	CcSEcCtD
Quinidine barbiturate—Oesophagitis—Docetaxel—melanoma	0.00237	0.00336	CcSEcCtD
Quinidine barbiturate—Neutropenia—Carmustine—melanoma	0.00237	0.00335	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Vemurafenib—melanoma	0.00237	0.00335	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Vemurafenib—melanoma	0.00235	0.00333	CcSEcCtD
Quinidine barbiturate—Haemoglobin—Bleomycin—melanoma	0.00234	0.0033	CcSEcCtD
Quinidine barbiturate—Constipation—Vemurafenib—melanoma	0.00233	0.0033	CcSEcCtD
Quinidine barbiturate—Pancytopenia—Temozolomide—melanoma	0.00233	0.00329	CcSEcCtD
Quinidine barbiturate—Haemorrhage—Bleomycin—melanoma	0.00233	0.00329	CcSEcCtD
Quinidine barbiturate—Pulmonary oedema—Docetaxel—melanoma	0.00231	0.00327	CcSEcCtD
Quinidine barbiturate—Neutropenia—Temozolomide—melanoma	0.00229	0.00324	CcSEcCtD
Quinidine barbiturate—Agranulocytosis—Dactinomycin—melanoma	0.00225	0.00319	CcSEcCtD
Quinidine barbiturate—Quinidine—ABCB1—melanoma	0.00225	0.24	CrCbGaD
Quinidine barbiturate—Photosensitivity reaction—Temozolomide—melanoma	0.00224	0.00316	CcSEcCtD
Quinidine barbiturate—Renal failure—Carmustine—melanoma	0.00222	0.00314	CcSEcCtD
Quinidine barbiturate—Hepatitis—Dactinomycin—melanoma	0.00217	0.00307	CcSEcCtD
Quinidine barbiturate—Stevens-Johnson syndrome—Temozolomide—melanoma	0.00217	0.00306	CcSEcCtD
Quinidine barbiturate—Flushing—Bleomycin—melanoma	0.00216	0.00305	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Vemurafenib—melanoma	0.00216	0.00305	CcSEcCtD
Quinidine barbiturate—Deafness—Docetaxel—melanoma	0.00211	0.00298	CcSEcCtD
Quinidine barbiturate—Chills—Bleomycin—melanoma	0.00209	0.00295	CcSEcCtD
Quinidine barbiturate—Erythema multiforme—Dactinomycin—melanoma	0.00205	0.0029	CcSEcCtD
Quinidine barbiturate—Haemoglobin—Carmustine—melanoma	0.00204	0.00288	CcSEcCtD
Quinidine barbiturate—Haemorrhage—Carmustine—melanoma	0.00203	0.00287	CcSEcCtD
Quinidine barbiturate—Erythema—Bleomycin—melanoma	0.00202	0.00286	CcSEcCtD
Quinidine barbiturate—Hallucination—Carmustine—melanoma	0.00202	0.00286	CcSEcCtD
Quinidine barbiturate—Flushing—Dactinomycin—melanoma	0.00201	0.00285	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Vemurafenib—melanoma	0.00201	0.00284	CcSEcCtD
Quinidine barbiturate—Visual disturbance—Docetaxel—melanoma	0.00199	0.00281	CcSEcCtD
Quinidine barbiturate—Renal impairment—Docetaxel—melanoma	0.00198	0.0028	CcSEcCtD
Quinidine barbiturate—Dermatitis bullous—Docetaxel—melanoma	0.00197	0.00279	CcSEcCtD
Quinidine barbiturate—Haemoglobin—Temozolomide—melanoma	0.00197	0.00279	CcSEcCtD
Quinidine barbiturate—Haemorrhage—Temozolomide—melanoma	0.00196	0.00277	CcSEcCtD
Quinidine barbiturate—Hepatitis—Temozolomide—melanoma	0.00196	0.00277	CcSEcCtD
Quinidine barbiturate—Asthenia—Vemurafenib—melanoma	0.00196	0.00277	CcSEcCtD
Quinidine barbiturate—Visual impairment—Carmustine—melanoma	0.00196	0.00277	CcSEcCtD
Quinidine barbiturate—Hallucination—Temozolomide—melanoma	0.00195	0.00276	CcSEcCtD
Quinidine barbiturate—Chills—Dactinomycin—melanoma	0.00195	0.00275	CcSEcCtD
Quinidine barbiturate—Urinary tract disorder—Temozolomide—melanoma	0.00194	0.00274	CcSEcCtD
Quinidine barbiturate—Pruritus—Vemurafenib—melanoma	0.00193	0.00273	CcSEcCtD
Quinidine barbiturate—Lethargy—Docetaxel—melanoma	0.00192	0.00272	CcSEcCtD
Quinidine barbiturate—Urethral disorder—Temozolomide—melanoma	0.00192	0.00272	CcSEcCtD
Quinidine barbiturate—Eye disorder—Carmustine—melanoma	0.0019	0.00268	CcSEcCtD
Quinidine barbiturate—Visual impairment—Temozolomide—melanoma	0.00189	0.00267	CcSEcCtD
Quinidine barbiturate—Erythema—Dactinomycin—melanoma	0.00189	0.00267	CcSEcCtD
Quinidine barbiturate—Flushing—Carmustine—melanoma	0.00188	0.00266	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Vemurafenib—melanoma	0.00187	0.00264	CcSEcCtD
Quinidine barbiturate—Erythema multiforme—Temozolomide—melanoma	0.00185	0.00262	CcSEcCtD
Quinidine barbiturate—Eye disorder—Temozolomide—melanoma	0.00183	0.00259	CcSEcCtD
Quinidine barbiturate—Tinnitus—Temozolomide—melanoma	0.00183	0.00259	CcSEcCtD
Quinidine barbiturate—Cardiac disorder—Temozolomide—melanoma	0.00182	0.00257	CcSEcCtD
Quinidine barbiturate—Flushing—Temozolomide—melanoma	0.00182	0.00257	CcSEcCtD
Quinidine barbiturate—Leukopenia—Bleomycin—melanoma	0.00181	0.00256	CcSEcCtD
Quinidine barbiturate—Dizziness—Vemurafenib—melanoma	0.0018	0.00255	CcSEcCtD
Quinidine barbiturate—Mental disorder—Carmustine—melanoma	0.00178	0.00251	CcSEcCtD
Quinidine barbiturate—Ataxia—Docetaxel—melanoma	0.00177	0.00251	CcSEcCtD
Quinidine barbiturate—Immune system disorder—Temozolomide—melanoma	0.00177	0.00251	CcSEcCtD
Quinidine barbiturate—Mediastinal disorder—Temozolomide—melanoma	0.00177	0.0025	CcSEcCtD
Quinidine barbiturate—Erythema—Carmustine—melanoma	0.00177	0.0025	CcSEcCtD
Quinidine barbiturate—Malnutrition—Carmustine—melanoma	0.00177	0.0025	CcSEcCtD
Quinidine barbiturate—Chills—Temozolomide—melanoma	0.00176	0.00249	CcSEcCtD
Quinidine barbiturate—Liver function test abnormal—Docetaxel—melanoma	0.00174	0.00246	CcSEcCtD
Quinidine barbiturate—Vomiting—Vemurafenib—melanoma	0.00173	0.00245	CcSEcCtD
Quinidine barbiturate—Chest pain—Bleomycin—melanoma	0.00172	0.00244	CcSEcCtD
Quinidine barbiturate—Myalgia—Bleomycin—melanoma	0.00172	0.00244	CcSEcCtD
Quinidine barbiturate—Orthostatic hypotension—Docetaxel—melanoma	0.00172	0.00243	CcSEcCtD
Quinidine barbiturate—Abdominal pain upper—Docetaxel—melanoma	0.00172	0.00243	CcSEcCtD
Quinidine barbiturate—Rash—Vemurafenib—melanoma	0.00172	0.00243	CcSEcCtD
Quinidine barbiturate—Mental disorder—Temozolomide—melanoma	0.00172	0.00243	CcSEcCtD
Quinidine barbiturate—Dermatitis—Vemurafenib—melanoma	0.00172	0.00243	CcSEcCtD
Quinidine barbiturate—Headache—Vemurafenib—melanoma	0.00171	0.00242	CcSEcCtD
Quinidine barbiturate—Malnutrition—Temozolomide—melanoma	0.00171	0.00241	CcSEcCtD
Quinidine barbiturate—Erythema—Temozolomide—melanoma	0.00171	0.00241	CcSEcCtD
Quinidine barbiturate—Breast disorder—Docetaxel—melanoma	0.0017	0.00241	CcSEcCtD
Quinidine barbiturate—Toxic epidermal necrolysis—Docetaxel—melanoma	0.0017	0.0024	CcSEcCtD
Quinidine barbiturate—Leukopenia—Dactinomycin—melanoma	0.00169	0.00239	CcSEcCtD
Quinidine barbiturate—Confusional state—Bleomycin—melanoma	0.00167	0.00236	CcSEcCtD
Quinidine barbiturate—Vision blurred—Carmustine—melanoma	0.00167	0.00235	CcSEcCtD
Quinidine barbiturate—Tremor—Carmustine—melanoma	0.00166	0.00234	CcSEcCtD
Quinidine barbiturate—Oedema—Bleomycin—melanoma	0.00165	0.00234	CcSEcCtD
Quinidine barbiturate—Agitation—Carmustine—melanoma	0.00162	0.0023	CcSEcCtD
Quinidine barbiturate—Nausea—Vemurafenib—melanoma	0.00162	0.00229	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Bleomycin—melanoma	0.00162	0.00229	CcSEcCtD
Quinidine barbiturate—Vision blurred—Temozolomide—melanoma	0.00161	0.00228	CcSEcCtD
Quinidine barbiturate—Myalgia—Dactinomycin—melanoma	0.00161	0.00227	CcSEcCtD
Quinidine barbiturate—Bronchospasm—Docetaxel—melanoma	0.0016	0.00227	CcSEcCtD
Quinidine barbiturate—Tremor—Temozolomide—melanoma	0.0016	0.00226	CcSEcCtD
Quinidine barbiturate—Angina pectoris—Docetaxel—melanoma	0.00159	0.00224	CcSEcCtD
Quinidine barbiturate—Leukopenia—Carmustine—melanoma	0.00158	0.00224	CcSEcCtD
Quinidine barbiturate—Anorexia—Bleomycin—melanoma	0.00157	0.00223	CcSEcCtD
Quinidine barbiturate—Agitation—Temozolomide—melanoma	0.00157	0.00222	CcSEcCtD
Quinidine barbiturate—Angioedema—Temozolomide—melanoma	0.00156	0.00221	CcSEcCtD
Quinidine barbiturate—Pancytopenia—Docetaxel—melanoma	0.00155	0.00219	CcSEcCtD
Quinidine barbiturate—Hypotension—Bleomycin—melanoma	0.00154	0.00218	CcSEcCtD
Quinidine barbiturate—Oedema—Dactinomycin—melanoma	0.00154	0.00218	CcSEcCtD
Quinidine barbiturate—Vertigo—Temozolomide—melanoma	0.00153	0.00217	CcSEcCtD
Quinidine barbiturate—Convulsion—Carmustine—melanoma	0.00153	0.00216	CcSEcCtD
Quinidine barbiturate—Leukopenia—Temozolomide—melanoma	0.00153	0.00216	CcSEcCtD
Quinidine barbiturate—Neutropenia—Docetaxel—melanoma	0.00152	0.00215	CcSEcCtD
Quinidine barbiturate—Palpitations—Temozolomide—melanoma	0.00151	0.00213	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Dactinomycin—melanoma	0.00151	0.00213	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Bleomycin—melanoma	0.0015	0.00213	CcSEcCtD
Quinidine barbiturate—Chest pain—Carmustine—melanoma	0.0015	0.00213	CcSEcCtD
Quinidine barbiturate—Myalgia—Carmustine—melanoma	0.0015	0.00213	CcSEcCtD
Quinidine barbiturate—Anxiety—Carmustine—melanoma	0.0015	0.00212	CcSEcCtD
Quinidine barbiturate—Convulsion—Temozolomide—melanoma	0.00148	0.00209	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Bleomycin—melanoma	0.00147	0.00208	CcSEcCtD
Quinidine barbiturate—Anorexia—Dactinomycin—melanoma	0.00147	0.00208	CcSEcCtD
Quinidine barbiturate—Confusional state—Carmustine—melanoma	0.00145	0.00206	CcSEcCtD
Quinidine barbiturate—Myalgia—Temozolomide—melanoma	0.00145	0.00206	CcSEcCtD
Quinidine barbiturate—Arthralgia—Temozolomide—melanoma	0.00145	0.00206	CcSEcCtD
Quinidine barbiturate—Anxiety—Temozolomide—melanoma	0.00145	0.00205	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00144	0.00204	CcSEcCtD
Quinidine barbiturate—Oedema—Carmustine—melanoma	0.00144	0.00204	CcSEcCtD
Quinidine barbiturate—Stevens-Johnson syndrome—Docetaxel—melanoma	0.00144	0.00204	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Bleomycin—melanoma	0.00144	0.00203	CcSEcCtD
Quinidine barbiturate—Renal failure—Docetaxel—melanoma	0.00143	0.00202	CcSEcCtD
Quinidine barbiturate—Jaundice—Docetaxel—melanoma	0.00142	0.002	CcSEcCtD
Quinidine barbiturate—Pain—Bleomycin—melanoma	0.00141	0.002	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Carmustine—melanoma	0.00141	0.002	CcSEcCtD
Quinidine barbiturate—Tachycardia—Carmustine—melanoma	0.00141	0.00199	CcSEcCtD
Quinidine barbiturate—Confusional state—Temozolomide—melanoma	0.00141	0.00199	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Dactinomycin—melanoma	0.0014	0.00198	CcSEcCtD
Quinidine barbiturate—Oedema—Temozolomide—melanoma	0.00139	0.00197	CcSEcCtD
Quinidine barbiturate—Anorexia—Carmustine—melanoma	0.00137	0.00194	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Temozolomide—melanoma	0.00137	0.00193	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Temozolomide—melanoma	0.00136	0.00193	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Bleomycin—melanoma	0.00136	0.00192	CcSEcCtD
Quinidine barbiturate—Agranulocytosis—Docetaxel—melanoma	0.00136	0.00192	CcSEcCtD
Quinidine barbiturate—Skin disorder—Temozolomide—melanoma	0.00135	0.00191	CcSEcCtD
Quinidine barbiturate—Hypotension—Carmustine—melanoma	0.00135	0.00191	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Temozolomide—melanoma	0.00135	0.0019	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Dactinomycin—melanoma	0.00134	0.00189	CcSEcCtD
Quinidine barbiturate—Anorexia—Temozolomide—melanoma	0.00133	0.00188	CcSEcCtD
Quinidine barbiturate—Pain—Dactinomycin—melanoma	0.00132	0.00186	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Carmustine—melanoma	0.00131	0.00186	CcSEcCtD
Quinidine barbiturate—Urticaria—Bleomycin—melanoma	0.00131	0.00186	CcSEcCtD
Quinidine barbiturate—Haemoglobin—Docetaxel—melanoma	0.00131	0.00185	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Bleomycin—melanoma	0.00131	0.00185	CcSEcCtD
Quinidine barbiturate—Haemorrhage—Docetaxel—melanoma	0.0013	0.00184	CcSEcCtD
Quinidine barbiturate—Hepatitis—Docetaxel—melanoma	0.0013	0.00184	CcSEcCtD
Quinidine barbiturate—Urinary tract disorder—Docetaxel—melanoma	0.00129	0.00182	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Carmustine—melanoma	0.00129	0.00182	CcSEcCtD
Quinidine barbiturate—Somnolence—Carmustine—melanoma	0.00128	0.00181	CcSEcCtD
Quinidine barbiturate—Urethral disorder—Docetaxel—melanoma	0.00128	0.00181	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Dactinomycin—melanoma	0.00127	0.0018	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Temozolomide—melanoma	0.00127	0.0018	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Dactinomycin—melanoma	0.00126	0.00178	CcSEcCtD
Quinidine barbiturate—Visual impairment—Docetaxel—melanoma	0.00126	0.00178	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Carmustine—melanoma	0.00125	0.00177	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Carmustine—melanoma	0.00124	0.00176	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Temozolomide—melanoma	0.00124	0.00176	CcSEcCtD
Quinidine barbiturate—Somnolence—Temozolomide—melanoma	0.00124	0.00175	CcSEcCtD
Quinidine barbiturate—Erythema multiforme—Docetaxel—melanoma	0.00123	0.00174	CcSEcCtD
Quinidine barbiturate—Pain—Carmustine—melanoma	0.00123	0.00174	CcSEcCtD
Quinidine barbiturate—Constipation—Carmustine—melanoma	0.00123	0.00174	CcSEcCtD
Quinidine barbiturate—Eye disorder—Docetaxel—melanoma	0.00122	0.00172	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Dactinomycin—melanoma	0.00122	0.00172	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Dactinomycin—melanoma	0.00122	0.00172	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Bleomycin—melanoma	0.00122	0.00172	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Temozolomide—melanoma	0.00121	0.00171	CcSEcCtD
Quinidine barbiturate—Flushing—Docetaxel—melanoma	0.00121	0.00171	CcSEcCtD
Quinidine barbiturate—Cardiac disorder—Docetaxel—melanoma	0.00121	0.00171	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Temozolomide—melanoma	0.0012	0.0017	CcSEcCtD
Quinidine barbiturate—Constipation—Temozolomide—melanoma	0.00119	0.00168	CcSEcCtD
Quinidine barbiturate—Pain—Temozolomide—melanoma	0.00119	0.00168	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Carmustine—melanoma	0.00119	0.00168	CcSEcCtD
Quinidine barbiturate—Asthenia—Bleomycin—melanoma	0.00119	0.00168	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Carmustine—melanoma	0.00118	0.00167	CcSEcCtD
Quinidine barbiturate—Immune system disorder—Docetaxel—melanoma	0.00118	0.00167	CcSEcCtD
Quinidine barbiturate—Mediastinal disorder—Docetaxel—melanoma	0.00118	0.00166	CcSEcCtD
Quinidine barbiturate—Chills—Docetaxel—melanoma	0.00117	0.00165	CcSEcCtD
Quinidine barbiturate—Pruritus—Bleomycin—melanoma	0.00117	0.00165	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Temozolomide—melanoma	0.00115	0.00162	CcSEcCtD
Quinidine barbiturate—Mental disorder—Docetaxel—melanoma	0.00114	0.00162	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Carmustine—melanoma	0.00114	0.00161	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Carmustine—melanoma	0.00114	0.00161	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Temozolomide—melanoma	0.00114	0.00161	CcSEcCtD
Quinidine barbiturate—Malnutrition—Docetaxel—melanoma	0.00114	0.00161	CcSEcCtD
Quinidine barbiturate—Erythema—Docetaxel—melanoma	0.00114	0.00161	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Dactinomycin—melanoma	0.00114	0.00161	CcSEcCtD
Quinidine barbiturate—Urticaria—Temozolomide—melanoma	0.00111	0.00157	CcSEcCtD
Quinidine barbiturate—Asthenia—Dactinomycin—melanoma	0.00111	0.00156	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Temozolomide—melanoma	0.0011	0.00156	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Temozolomide—melanoma	0.0011	0.00156	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Carmustine—melanoma	0.00106	0.0015	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Dactinomycin—melanoma	0.00105	0.00149	CcSEcCtD
Quinidine barbiturate—Vomiting—Bleomycin—melanoma	0.00105	0.00149	CcSEcCtD
Quinidine barbiturate—Rash—Bleomycin—melanoma	0.00104	0.00147	CcSEcCtD
Quinidine barbiturate—Dermatitis—Bleomycin—melanoma	0.00104	0.00147	CcSEcCtD
Quinidine barbiturate—Asthenia—Carmustine—melanoma	0.00103	0.00146	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Temozolomide—melanoma	0.00103	0.00145	CcSEcCtD
Quinidine barbiturate—Phenobarbital—ABCB1—melanoma	0.00102	0.109	CrCbGaD
Quinidine barbiturate—Syncope—Docetaxel—melanoma	0.00102	0.00144	CcSEcCtD
Quinidine barbiturate—Leukopenia—Docetaxel—melanoma	0.00102	0.00144	CcSEcCtD
Quinidine barbiturate—Palpitations—Docetaxel—melanoma	0.001	0.00142	CcSEcCtD
Quinidine barbiturate—Asthenia—Temozolomide—melanoma	0.001	0.00141	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Docetaxel—melanoma	0.000998	0.00141	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Carmustine—melanoma	0.000987	0.0014	CcSEcCtD
Quinidine barbiturate—Pruritus—Temozolomide—melanoma	0.000986	0.00139	CcSEcCtD
Quinidine barbiturate—Convulsion—Docetaxel—melanoma	0.000984	0.00139	CcSEcCtD
Quinidine barbiturate—Nausea—Bleomycin—melanoma	0.000981	0.00139	CcSEcCtD
Quinidine barbiturate—Vomiting—Dactinomycin—melanoma	0.00098	0.00139	CcSEcCtD
Quinidine barbiturate—Rash—Dactinomycin—melanoma	0.000971	0.00137	CcSEcCtD
Quinidine barbiturate—Arthralgia—Docetaxel—melanoma	0.000967	0.00137	CcSEcCtD
Quinidine barbiturate—Chest pain—Docetaxel—melanoma	0.000967	0.00137	CcSEcCtD
Quinidine barbiturate—Myalgia—Docetaxel—melanoma	0.000967	0.00137	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.00096	0.00136	CcSEcCtD
Quinidine barbiturate—Dizziness—Carmustine—melanoma	0.000954	0.00135	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Temozolomide—melanoma	0.000953	0.00135	CcSEcCtD
Quinidine barbiturate—Confusional state—Docetaxel—melanoma	0.000934	0.00132	CcSEcCtD
Quinidine barbiturate—Oedema—Docetaxel—melanoma	0.000927	0.00131	CcSEcCtD
Quinidine barbiturate—Dizziness—Temozolomide—melanoma	0.000921	0.0013	CcSEcCtD
Quinidine barbiturate—Vomiting—Carmustine—melanoma	0.000917	0.0013	CcSEcCtD
Quinidine barbiturate—Nausea—Dactinomycin—melanoma	0.000915	0.00129	CcSEcCtD
Quinidine barbiturate—Shock—Docetaxel—melanoma	0.000912	0.00129	CcSEcCtD
Quinidine barbiturate—Rash—Carmustine—melanoma	0.000909	0.00129	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Docetaxel—melanoma	0.000909	0.00129	CcSEcCtD
Quinidine barbiturate—Dermatitis—Carmustine—melanoma	0.000908	0.00128	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Docetaxel—melanoma	0.000907	0.00128	CcSEcCtD
Quinidine barbiturate—Tachycardia—Docetaxel—melanoma	0.000904	0.00128	CcSEcCtD
Quinidine barbiturate—Headache—Carmustine—melanoma	0.000903	0.00128	CcSEcCtD
Quinidine barbiturate—Skin disorder—Docetaxel—melanoma	0.0009	0.00127	CcSEcCtD
Quinidine barbiturate—Vomiting—Temozolomide—melanoma	0.000886	0.00125	CcSEcCtD
Quinidine barbiturate—Anorexia—Docetaxel—melanoma	0.000883	0.00125	CcSEcCtD
Quinidine barbiturate—Rash—Temozolomide—melanoma	0.000879	0.00124	CcSEcCtD
Quinidine barbiturate—Dermatitis—Temozolomide—melanoma	0.000878	0.00124	CcSEcCtD
Quinidine barbiturate—Headache—Temozolomide—melanoma	0.000873	0.00123	CcSEcCtD
Quinidine barbiturate—Hypotension—Docetaxel—melanoma	0.000866	0.00122	CcSEcCtD
Quinidine barbiturate—Nausea—Carmustine—melanoma	0.000856	0.00121	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Docetaxel—melanoma	0.000844	0.00119	CcSEcCtD
Quinidine barbiturate—Nausea—Temozolomide—melanoma	0.000828	0.00117	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Docetaxel—melanoma	0.000826	0.00117	CcSEcCtD
Quinidine barbiturate—Somnolence—Docetaxel—melanoma	0.000824	0.00116	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Docetaxel—melanoma	0.000806	0.00114	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Docetaxel—melanoma	0.0008	0.00113	CcSEcCtD
Quinidine barbiturate—Constipation—Docetaxel—melanoma	0.000792	0.00112	CcSEcCtD
Quinidine barbiturate—Pain—Docetaxel—melanoma	0.000792	0.00112	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Docetaxel—melanoma	0.000764	0.00108	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Docetaxel—melanoma	0.000758	0.00107	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Docetaxel—melanoma	0.000733	0.00104	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Docetaxel—melanoma	0.000733	0.00104	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Docetaxel—melanoma	0.000683	0.000965	CcSEcCtD
Quinidine barbiturate—Asthenia—Docetaxel—melanoma	0.000665	0.00094	CcSEcCtD
Quinidine barbiturate—Pruritus—Docetaxel—melanoma	0.000656	0.000927	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Docetaxel—melanoma	0.000634	0.000897	CcSEcCtD
Quinidine barbiturate—Dizziness—Docetaxel—melanoma	0.000613	0.000866	CcSEcCtD
Quinidine barbiturate—Vomiting—Docetaxel—melanoma	0.000589	0.000833	CcSEcCtD
Quinidine barbiturate—Rash—Docetaxel—melanoma	0.000584	0.000826	CcSEcCtD
Quinidine barbiturate—Dermatitis—Docetaxel—melanoma	0.000584	0.000825	CcSEcCtD
Quinidine barbiturate—Headache—Docetaxel—melanoma	0.000581	0.000821	CcSEcCtD
Quinidine barbiturate—Nausea—Docetaxel—melanoma	0.00055	0.000778	CcSEcCtD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—GRM1—melanoma	0.000173	0.000611	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CCR7—melanoma	0.000173	0.000611	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—MMP9—melanoma	0.000172	0.000608	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—MAPK1—melanoma	0.000172	0.000608	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—KISS1—melanoma	0.000172	0.000607	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	0.000169	0.000597	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—CASP3—melanoma	0.000169	0.000596	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—ABCB1—melanoma	0.000168	0.000593	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CXCR1—melanoma	0.000167	0.000588	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—MC1R—melanoma	0.000164	0.000579	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—MMP2—melanoma	0.000164	0.000578	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—MAP2K1—melanoma	0.000163	0.000577	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—CTNNB1—melanoma	0.000163	0.000574	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—MAPK1—melanoma	0.000158	0.000559	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—NFKB1—melanoma	0.000158	0.000557	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—RHOB—melanoma	0.000158	0.000556	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—GRM1—melanoma	0.000157	0.000555	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CCR7—melanoma	0.000157	0.000555	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—TNF—melanoma	0.000157	0.000554	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—FGF2—melanoma	0.000155	0.000549	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—VEGFA—melanoma	0.000155	0.000546	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—NRAS—melanoma	0.000153	0.00054	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—MAPK1—melanoma	0.000152	0.000537	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—MDM2—melanoma	0.000151	0.000534	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ACER3—melanoma	0.00015	0.00053	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—NRAS—melanoma	0.000147	0.000518	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—MAPK3—melanoma	0.000146	0.000517	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	0.000144	0.000509	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CXCR2—melanoma	0.000144	0.000507	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—ERBB2—melanoma	0.000143	0.000506	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—ABCB1—melanoma	0.000143	0.000506	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—VEGFA—melanoma	0.000143	0.000506	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—RHOB—melanoma	0.000143	0.000505	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—EDN1—melanoma	0.000142	0.000502	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—RAC2—melanoma	0.000141	0.000498	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—MAPK3—melanoma	0.000141	0.000496	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—MAPK1—melanoma	0.000139	0.000492	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—EGFR—melanoma	0.000139	0.000492	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—HRAS—melanoma	0.000138	0.000488	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—UGT2B10—melanoma	0.000137	0.000485	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—MAPK1—melanoma	0.000135	0.000477	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PLCB4—melanoma	0.000134	0.000473	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CXCL1—melanoma	0.000134	0.000473	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—MAPK1—melanoma	0.000134	0.000472	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—EGFR—melanoma	0.000134	0.000472	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—KRAS—melanoma	0.000132	0.000464	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CXCR2—melanoma	0.00013	0.00046	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—RAC2—melanoma	0.000128	0.000453	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—HS3ST5—melanoma	0.000128	0.000451	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—HRAS—melanoma	0.000127	0.000449	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—CXCL8—melanoma	0.000127	0.000449	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—IL6—melanoma	0.000127	0.000447	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—KRAS—melanoma	0.000126	0.000446	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—WNT5A—melanoma	0.000126	0.000445	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CUL3—melanoma	0.000126	0.000445	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TRRAP—melanoma	0.000126	0.000445	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—CTNNB1—melanoma	0.000125	0.000443	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—MMP9—melanoma	0.000123	0.000434	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—TNF—melanoma	0.000123	0.000433	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—AKR1B10—melanoma	0.000123	0.000433	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—HRAS—melanoma	0.000122	0.000431	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—F2R—melanoma	0.000122	0.000431	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—NFKB1—melanoma	0.000122	0.00043	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—MAPK1—melanoma	0.000121	0.000428	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—EDNRB—melanoma	0.000118	0.000417	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—melanoma	0.000116	0.00041	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—F2RL1—melanoma	0.000114	0.000402	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—HRAS—melanoma	0.000112	0.000395	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—GNA11—melanoma	0.000112	0.000394	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—GAB2—melanoma	0.000112	0.000394	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—F2R—melanoma	0.000111	0.000391	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—VEGFA—melanoma	0.00011	0.00039	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—STAT3—melanoma	0.000109	0.000386	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—NRAS—melanoma	0.000109	0.000385	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—HRAS—melanoma	0.000108	0.000383	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—EDNRB—melanoma	0.000107	0.000379	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GRM3—melanoma	0.000107	0.000378	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—IL6—melanoma	0.000107	0.000378	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—ALB—melanoma	0.000105	0.000371	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CXCR4—melanoma	0.000105	0.00037	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—MAPK3—melanoma	0.000105	0.000369	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—GNAQ—melanoma	0.000104	0.000366	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—MAPK1—melanoma	0.000103	0.000365	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—KISS1—melanoma	0.000102	0.000359	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—GAB2—melanoma	0.000101	0.000358	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—GNA11—melanoma	0.000101	0.000358	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—melanoma	0.000101	0.000357	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—MAPK1—melanoma	9.94e-05	0.000351	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—EGFR—melanoma	9.94e-05	0.000351	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—IL6—melanoma	9.91e-05	0.00035	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SKI—melanoma	9.84e-05	0.000347	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CXCR1—melanoma	9.84e-05	0.000347	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—HRAS—melanoma	9.74e-05	0.000344	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MC1R—melanoma	9.69e-05	0.000342	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PLCB4—melanoma	9.68e-05	0.000342	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—AKT3—melanoma	9.58e-05	0.000338	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CXCR4—melanoma	9.53e-05	0.000336	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—TNF—melanoma	9.47e-05	0.000334	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—GNAQ—melanoma	9.43e-05	0.000333	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—KRAS—melanoma	9.39e-05	0.000331	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GRM1—melanoma	9.29e-05	0.000328	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CCR7—melanoma	9.29e-05	0.000328	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SLC6A11—melanoma	9.1e-05	0.000321	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PIP4K2A—melanoma	9.1e-05	0.000321	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SUFU—melanoma	9.06e-05	0.00032	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—ALB—melanoma	8.97e-05	0.000316	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—MTAP—melanoma	8.86e-05	0.000312	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—AKT3—melanoma	8.7e-05	0.000307	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—BCL2L11—melanoma	8.46e-05	0.000298	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—RHOB—melanoma	8.46e-05	0.000298	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—HRAS—melanoma	8.31e-05	0.000293	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HDAC6—melanoma	8.12e-05	0.000287	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—EDN1—melanoma	8.05e-05	0.000284	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—HRAS—melanoma	7.98e-05	0.000282	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—LUM—melanoma	7.89e-05	0.000278	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PHGDH—melanoma	7.89e-05	0.000278	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CSF2—melanoma	7.87e-05	0.000278	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—HPSE—melanoma	7.74e-05	0.000273	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CXCR2—melanoma	7.7e-05	0.000272	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CXCL8—melanoma	7.7e-05	0.000272	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—IL6—melanoma	7.64e-05	0.00027	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CUBN—melanoma	7.6e-05	0.000268	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—RAC2—melanoma	7.58e-05	0.000267	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PRKCA—melanoma	7.54e-05	0.000266	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—VEGFC—melanoma	7.46e-05	0.000263	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—WNT5A—melanoma	7.46e-05	0.000263	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SDHD—melanoma	7.34e-05	0.000259	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—BSG—melanoma	7.34e-05	0.000259	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CSPG4—melanoma	7.34e-05	0.000259	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—EDN1—melanoma	7.31e-05	0.000258	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CSF2—melanoma	7.14e-05	0.000252	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GPAM—melanoma	7.11e-05	0.000251	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—AKT1—melanoma	7.05e-05	0.000249	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—RAC1—melanoma	6.99e-05	0.000247	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PRKCA—melanoma	6.85e-05	0.000242	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—MAP2K2—melanoma	6.69e-05	0.000236	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—F2R—melanoma	6.55e-05	0.000231	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—RAC1—melanoma	6.35e-05	0.000224	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—EDNRB—melanoma	6.34e-05	0.000224	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PTK2B—melanoma	6.16e-05	0.000217	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PLA2G6—melanoma	6.04e-05	0.000213	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GNA11—melanoma	5.99e-05	0.000211	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GAB2—melanoma	5.99e-05	0.000211	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—FLT1—melanoma	5.96e-05	0.00021	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PIK3CG—melanoma	5.91e-05	0.000208	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—FOXO4—melanoma	5.63e-05	0.000199	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CXCR4—melanoma	5.63e-05	0.000199	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HDAC2—melanoma	5.63e-05	0.000199	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GNAQ—melanoma	5.57e-05	0.000196	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—VCAN—melanoma	5.43e-05	0.000192	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PIK3CG—melanoma	5.36e-05	0.000189	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SYK—melanoma	5.23e-05	0.000185	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PIK3CD—melanoma	5.19e-05	0.000183	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—AKT3—melanoma	5.14e-05	0.000181	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NGFR—melanoma	5.14e-05	0.000181	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ITGAV—melanoma	5.14e-05	0.000181	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SOCS1—melanoma	4.76e-05	0.000168	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—MAP2K1—melanoma	4.75e-05	0.000167	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—S100B—melanoma	4.75e-05	0.000167	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PIK3CD—melanoma	4.72e-05	0.000166	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYP17A1—melanoma	4.58e-05	0.000162	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ERBB4—melanoma	4.54e-05	0.00016	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PIK3CB—melanoma	4.53e-05	0.00016	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CDKN2B—melanoma	4.5e-05	0.000159	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CD86—melanoma	4.35e-05	0.000154	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CXCL8—melanoma	4.35e-05	0.000153	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GNA11—melanoma	4.32e-05	0.000153	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—EDN1—melanoma	4.32e-05	0.000152	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—FASN—melanoma	4.23e-05	0.000149	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CSF2—melanoma	4.22e-05	0.000149	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—FGF1—melanoma	4.22e-05	0.000149	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SLC5A5—melanoma	4.16e-05	0.000147	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—IL2—melanoma	4.16e-05	0.000147	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—E2F1—melanoma	4.13e-05	0.000146	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PIK3CB—melanoma	4.11e-05	0.000145	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PDGFRA—melanoma	4.09e-05	0.000144	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PRKCA—melanoma	4.05e-05	0.000143	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ITGB3—melanoma	4.05e-05	0.000143	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GNAQ—melanoma	4.02e-05	0.000142	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CD44—melanoma	4.02e-05	0.000142	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SPP1—melanoma	3.97e-05	0.00014	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MAP2K2—melanoma	3.95e-05	0.00014	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CXCL8—melanoma	3.95e-05	0.000139	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYP1B1—melanoma	3.85e-05	0.000136	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—IL2—melanoma	3.77e-05	0.000133	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TERT—melanoma	3.76e-05	0.000133	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—RAC1—melanoma	3.75e-05	0.000132	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HIF1A—melanoma	3.6e-05	0.000127	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—KDR—melanoma	3.44e-05	0.000121	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—FN1—melanoma	3.31e-05	0.000117	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NOTCH1—melanoma	3.24e-05	0.000114	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CD80—melanoma	3.17e-05	0.000112	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ABCB1—melanoma	3.17e-05	0.000112	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PIK3CG—melanoma	3.17e-05	0.000112	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—APC—melanoma	3.17e-05	0.000112	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—KIT—melanoma	3.17e-05	0.000112	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—NRAS—melanoma	3.17e-05	0.000112	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—EGF—melanoma	3.13e-05	0.000111	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—MAPK3—melanoma	3.03e-05	0.000107	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—BRAF—melanoma	2.98e-05	0.000105	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PRKCA—melanoma	2.92e-05	0.000103	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IGF1—melanoma	2.9e-05	0.000102	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ERCC2—melanoma	2.9e-05	0.000102	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—MAPK1—melanoma	2.89e-05	0.000102	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—EGFR—melanoma	2.89e-05	0.000102	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MAP2K1—melanoma	2.8e-05	9.89e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PIK3CD—melanoma	2.79e-05	9.83e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PIK3CA—melanoma	2.76e-05	9.74e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—KRAS—melanoma	2.73e-05	9.62e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—FGF2—melanoma	2.67e-05	9.41e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PIK3CA—melanoma	2.51e-05	8.84e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MDM2—melanoma	2.5e-05	8.81e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ERBB2—melanoma	2.46e-05	8.68e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PIK3CB—melanoma	2.43e-05	8.57e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CXCL8—melanoma	2.33e-05	8.23e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—HRAS—melanoma	2.32e-05	8.18e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PIK3CG—melanoma	2.29e-05	8.07e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CDKN1B—melanoma	2.28e-05	8.04e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—AKT1—melanoma	2.25e-05	7.95e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CASP3—melanoma	2.23e-05	7.88e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IL2—melanoma	2.23e-05	7.87e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—IL6—melanoma	2.22e-05	7.83e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PPARG—melanoma	2.21e-05	7.79e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CCND1—melanoma	2.17e-05	7.67e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CTNNB1—melanoma	2.15e-05	7.6e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MMP9—melanoma	2.11e-05	7.45e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CDKN1A—melanoma	2.1e-05	7.42e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PTEN—melanoma	2.1e-05	7.4e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NFKB1—melanoma	2.09e-05	7.37e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—AKT1—melanoma	2.05e-05	7.22e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PIK3CD—melanoma	2.01e-05	7.1e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ALB—melanoma	1.99e-05	7.01e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—VEGFA—melanoma	1.9e-05	6.69e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—STAT3—melanoma	1.88e-05	6.62e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NRAS—melanoma	1.87e-05	6.6e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MAPK3—melanoma	1.79e-05	6.33e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PIK3CB—melanoma	1.75e-05	6.19e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MYC—melanoma	1.74e-05	6.15e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PTGS2—melanoma	1.74e-05	6.13e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MAPK1—melanoma	1.71e-05	6.02e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—EGFR—melanoma	1.71e-05	6.02e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—KRAS—melanoma	1.61e-05	5.68e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PTEN—melanoma	1.52e-05	5.35e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PIK3CA—melanoma	1.48e-05	5.22e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TP53—melanoma	1.43e-05	5.05e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HRAS—melanoma	1.37e-05	4.83e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IL6—melanoma	1.31e-05	4.62e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—AKT1—melanoma	1.21e-05	4.27e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PIK3CA—melanoma	1.07e-05	3.77e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—AKT1—melanoma	8.73e-06	3.08e-05	CbGpPWpGaD
